MedTrace Logo

Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH

NCT00417157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2013-12-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of a modified natural cycle in patients with previous poor response to infertility drugs and high basal FSH, prior to proceeding to oocyte donation or abandoning fertility treatment.

Conditions

Interventions

DRUG

recombinant FSH (Puregon, Organon, The Netherlands)

DRUG

GnRH antag: Ganirelix (Orgalutran, Organon, The Netherlands)

DRUG

hCG (Pregnyl, Organon, The Netherlands)

Sponsors & Collaborators

  • Eugonia

    lead OTHER

Principal Investigators

  • Tryfon Lainas, PhD · Eugonia

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00417157 on ClinicalTrials.gov